These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7974358)

  • 21. A metabolic syndrome independent association between overweight, fibrinolysis impairment and low-grade inflammation in young women with venous thromboembolism.
    Salobir B; Sabovic M
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):551-6. PubMed ID: 16988550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysis Timer: a new sensitive tool to diagnose hyperfibrinolysis in liver transplantation.
    Roullet S; Labrouche S; Mouton C; Quinart A; Nouette-Gaulain K; Laurent C; Freyburger G
    J Clin Pathol; 2019 Jan; 72(1):58-65. PubMed ID: 30282673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation and fibrinolysis in primary biliary cirrhosis compared with other liver disease and during orthotopic liver transplantation.
    Segal H; Cottam S; Potter D; Hunt BJ
    Hepatology; 1997 Mar; 25(3):683-8. PubMed ID: 9049219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The increase of leg fibrinolytic potential after reduction of hydrostatic stimulus.
    Keber D
    Thromb Haemost; 1983 Oct; 50(3):731-4. PubMed ID: 6685927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of blood passage through the pulmonary circulation on fibrinolytic parameters.
    Kloboves-Prevodnik V; Sabovic M; Keber D
    Heart Vessels; 2004 Jan; 19(1):33-7. PubMed ID: 14685753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation.
    Nielsen VG; Cohen BM; Cohen E
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):75-81. PubMed ID: 16607085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel mechanism to enhance tPA-induced fibrinolysis: effect of limited proteolysis of PAI-1 by neutrophil elastase.
    Urano T; Wu K; Ihara H; Takada Y; Takada A
    Pol J Pharmacol; 1996; 48(2):209-13. PubMed ID: 9112653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
    Robbie LA; Booth NA; Croll AM; Bennett B
    Thromb Haemost; 1993 Aug; 70(2):301-6. PubMed ID: 8236139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinolysis and coagulation. I. Effect of calcium on lysis of euglobulin clots.
    Helle I
    Scand J Haematol; 1967; 4(1):21-32. PubMed ID: 4961989
    [No Abstract]   [Full Text] [Related]  

  • 31. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clot life span model analysis of clot growth and fibrinolysis in normal subjects: role of thrombin activatable fibrinolysis inhibitor.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):283-7. PubMed ID: 18469549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
    Nakamura R; Umemura K; Hashimmoto H; Urano T
    Thromb Haemost; 2006 Apr; 95(4):637-42. PubMed ID: 16601834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
    Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
    Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC
    Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dihydropyridine calcium antagonists increase fibrinolytic activity: a systematic review.
    Vergouwen MD; Vermeulen M; de Haan RJ; Levi M; Roos YB
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1293-308. PubMed ID: 17191079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening.
    Kostka B; Para J; Sikora J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodilution modulates the time of onset and rate of fibrinolysis in human and rabbit plasma.
    Nielsen VG
    J Heart Lung Transplant; 2006 Nov; 25(11):1344-52. PubMed ID: 17097499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fibrinolytic and peripheral serotonergic system in patients with glomerulonephritis].
    Małyszko J; Małyszko J; Myśliwiec M; Pawlak D; Buczko W
    Przegl Lek; 1995; 52(9):428-30. PubMed ID: 8834642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clot lifespan model analysis of the effects of warfarin on thrombus growth and fibrinolysis: role of contact protein and tissue factor initiation.
    Nielsen VG; Kirklin JK; Holman WL; Steenwyk BL
    ASAIO J; 2009; 55(1):33-40. PubMed ID: 19092656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.